Clinical Trial Update: Prevention of Recurrent Venous Thromboembolism (PREVENT) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial (PREVENT) sponsored by the National Heart, Lung, and Blood Institute evaluating prevention of recurrent venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: COMPLETED